Related Experiment Video
Updated: Mar 17, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
How much do we really know about von Willebrand disease?
Laura L Swystun1, David Lillicrap
1Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Von Willebrand disease (VWD) is the most common inherited bleeding disorder. Advances in understanding its genetic basis are improving diagnostics and treatments, especially for type 1 VWD.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Von Willebrand disease (VWD) is the most prevalent inherited bleeding disorder.
- Pathological variations at the von Willebrand factor (VWF) locus cause quantitative and qualitative abnormalities.
- This review focuses on the pathobiological basis of VWD.
Purpose of the Study:
- To review the current understanding of the pathobiological basis of VWD.
- To highlight advances in characterizing VWD, particularly type 1.
- To discuss the implications for diagnostics and treatment.
Main Methods:
- Review of recent decades' research on VWD.
- Analysis of molecular basis for VWD types 1, 2, and 3.
- Inclusion of findings from genome-wide association studies and linkage analyses.
Main Results:
- The molecular basis of VWD types 2 and 3 is well-characterized.
- Type 1 VWD remains incompletely understood due to genetic heterogeneity and modifying factors.
- Genome-wide studies aim to identify genes influencing type 1 VWD phenotype.
Conclusions:
- Understanding VWD pathogenesis is crucial for developing novel treatments.
- Improved molecular diagnostics for type 1 VWD are a key outcome.
- Continued research into genetic modifiers will enhance VWD management.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

